These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24071521)

  • 1. High-fat-cholesterol diet mainly induced necrosis in fibrotic steatohepatitis rat by suppressing caspase activity.
    Yetti H; Naito H; Jia X; Shindo M; Taki H; Tamada H; Kitamori K; Hayashi Y; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2013 Nov; 93(18-19):673-80. PubMed ID: 24071521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.
    Naito H; Jia X; Yetti H; Yanagiba Y; Tamada H; Kitamori K; Hayashi Y; Wang D; Kato M; Ishii A; Nakajima T
    Environ Health Prev Med; 2016 Sep; 21(5):368-381. PubMed ID: 27209494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
    Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
    Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
    Watanabe S; Kumazaki S; Kusunoki K; Inoue T; Maeda Y; Usui S; Shinohata R; Ohtsuki T; Hirohata S; Kusachi S; Kitamori K; Mori M; Yamori Y; Oka H
    J Atheroscler Thromb; 2018 May; 25(5):439-453. PubMed ID: 29162773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
    Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    Yetti H; Naito H; Yuan Y; Jia X; Hayashi Y; Tamada H; Kitamori K; Ikeda K; Yamori Y; Nakajima T
    PLoS One; 2018; 13(2):e0192863. PubMed ID: 29438418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Komeda K; Masubuchi S; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2017 Jul; 134(3):139-146. PubMed ID: 28673635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHRSP5/Dmcr rats fed a high-fat and high-cholesterol diet develop disease-induced sarcopenia as nonalcoholic steatohepatitis progresses.
    Yamamoto S; Honma K; Fujii M; Kakimoto M; Kirihara S; Nakayama H; Kitamori K; Sato I; Hirohata S; Watanabe S
    Ann Anat; 2023 Aug; 249():152104. PubMed ID: 37209870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.
    Tamada H; Naito H; Kitamori K; Hayashi Y; Yamagishi N; Kato M; Nakajima T
    PLoS One; 2016; 11(1):e0145939. PubMed ID: 26727365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
    Watanabe S; Kumazaki S; Yamamoto S; Sato I; Kitamori K; Mori M; Yamori Y; Hirohata S
    Int J Exp Pathol; 2018 Dec; 99(6):282-294. PubMed ID: 30680827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Masubuchi S; Ozeki M; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    Exp Anim; 2018 May; 67(2):239-247. PubMed ID: 29311502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis.
    Ichimura M; Masuzumi M; Kawase M; Sakaki M; Tamaru S; Nagata Y; Tanaka K; Suruga K; Tsuneyama K; Matsuda S; Omagari K
    J Nutr Biochem; 2017 Feb; 40():62-69. PubMed ID: 27863346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Wang D; Yanagiba Y; Wang J; Ikeda K; Yamori Y; Nakajima T
    Dig Dis Sci; 2013 Aug; 58(8):2212-22. PubMed ID: 23824403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
    Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-fat and high-cholesterol diet decreases phosphorylated inositol-requiring kinase-1 and inhibits autophagy process in rat liver.
    Naito H; Yoshikawa-Bando Y; Yuan Y; Hashimoto S; Kitamori K; Yatsuya H; Nakajima T
    Sci Rep; 2019 Aug; 9(1):12514. PubMed ID: 31467308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.